Since certain strains of both FIV and HIV use HSPG and CXCR4 for infection, it is attractive to design and synthesize heparin-derivatives or analogues that can work on both steps for HSPG and CXCR4 interaction with SU for HIV treatment. The gene discussed is CXCR4; the disease is infection.